Measles-Mumps-Rubella Vaccine
"Measles-Mumps-Rubella Vaccine" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A combined vaccine used to prevent MEASLES; MUMPS; and RUBELLA.
| Descriptor ID |
D022542
|
| MeSH Number(s) |
D20.215.894.815.500 D20.215.894.899.404.500 D20.215.894.899.488.500 D20.215.894.899.779.500
|
| Concept/Terms |
Measles-Mumps-Rubella Vaccine- Measles-Mumps-Rubella Vaccine
- Measles Mumps Rubella Vaccine
- Vaccine, Measles-Mumps-Rubella
- Measles, Mumps, Rubella Vaccine
- MMR Vaccine
- Vaccine, MMR
- Mumps-Measles-Rubella Vaccine
- Mumps Measles Rubella Vaccine
- Vaccine, Mumps-Measles-Rubella
|
Below are MeSH descriptors whose meaning is more general than "Measles-Mumps-Rubella Vaccine".
Below are MeSH descriptors whose meaning is more specific than "Measles-Mumps-Rubella Vaccine".
This graph shows the total number of publications written about "Measles-Mumps-Rubella Vaccine" by people in this website by year, and whether "Measles-Mumps-Rubella Vaccine" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2010 | 1 | 0 | 1 |
| 2015 | 0 | 1 | 1 |
| 2022 | 0 | 1 | 1 |
| 2023 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Measles-Mumps-Rubella Vaccine" by people in Profiles.
-
Verma SK, Shah D, Singh A, Singh PK, Das S, Gupta P. Immunogenicity of measles-rubella vaccine administered under India's Universal Immunization Programme in the context of measles-rubella elimination goal: A longitudinal study. Indian J Med Res. 2023 04; 157(4):250-258.
-
Seaman MS, Siedner MJ, Boucau J, Lavine CL, Ghantous F, Liew MY, Mathews JI, Singh A, Marino C, Regan J, Uddin R, Choudhary MC, Flynn JP, Chen G, Stuckwisch AM, Lipiner T, Kittilson A, Melberg M, Gilbert RF, Reynolds Z, Iyer SL, Chamberlin GC, Vyas TD, Vyas JM, Goldberg MB, Luban J, Li JZ, Barczak AK, Lemieux JE. Vaccine breakthrough infection leads to distinct profiles of neutralizing antibody responses by SARS-CoV-2 variant. JCI Insight. 2022 10 10; 7(19).
-
Shah GL, Shune L, Purtill D, Devlin S, Lauer E, Lubin M, Bhatt V, McElrath C, Kernan NA, Scaradavou A, Giralt S, Perales MA, Ponce DM, Young JW, Shah M, Papanicolaou G, Barker JN. Robust Vaccine Responses in Adult and Pediatric Cord Blood Transplantation Recipients Treated for Hematologic Malignancies. Biol Blood Marrow Transplant. 2015 Dec; 21(12):2160-2166.
-
Latner DR, McGrew M, Williams N, Lowe L, Werman R, Warnock E, Gallagher K, Doyle P, Smole S, Lett S, Cocoros N, DeMaria A, Konomi R, Brown CJ, Rota PA, Bellini WJ, Hickman CJ. Enzyme-linked immunospot assay detection of mumps-specific antibody-secreting B cells as an alternative method of laboratory diagnosis. Clin Vaccine Immunol. 2011 Jan; 18(1):35-42.
-
Vivier PM, Alario AJ, Simon P, Flanagan P, O'Haire C, Peter G. Immunization status of children enrolled in a hospital-based medicaid managed care practice: the importance of the timing of vaccine administration. Pediatr Infect Dis J. 1999 Sep; 18(9):783-8.